European Union medicines chief is 'firmly convinced' AstraZeneca's COVID-19 vaccine is worth getting


Sweden joined its Scandinavian neighbors and several other European countries on Tuesday in suspending use of the Oxford-AstraZeneca COVID-19 vaccine, citing reports of blood clotting among vaccine recipients. Thirteen European Union countries — including Germany, France, Italy, and Spain — have suspended use of the AstraZeneca vaccine until a review, expected Thursday, from the EU's drug regulator, the European Medicines Agency. EMA chief Emer Cooke urged those nations to resume vaccinations.
"We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing COVID-19 with its associated risk of hospitalization and death outweigh the risk of the side effects," Cooke said Tuesday. "At present there is no indication that vaccination has caused these conditions," but "this is a serious concern and it does need serious and detailed scientific evaluation." The World Health Organization and AstraZeneca also say there's no evidence the vaccine increases risk of blood clots.
Health authorities in the countries suspending use of the vaccine concede the lack of evidence but say they are acting out of an abundance of caution. Even with Poland, Romania, Greece, Belgium, and other EU countries continuing to use AstraZeneca's vaccine, almost half the bloc's 15 million doses are lying in storage even as European countries struggle to vaccinate their populations.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Somalia's health minister and Thailand's prime minister got the AstraZeneca vaccine publicly to boost confidence in the shot. Thailand was the first non-European country to suspend use of the AstraZeneca vaccine but reversed course Tuesday. "There are people who have concerns," Prime Minister Prayuth Chan-ocha said after getting the shot. "But we must believe doctors, believe in our medical professionals."
AstraZeneca got more bad news Tuesday when a study from South Africa published in The New England Journal of Medicine showed the vaccine offered essentially no protection against mild or moderate infections from the South African variant of the coronavirus, B.1.351.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Money dysmorphia: why people think they're poorer than they are
In The Spotlight Wealthy people and the young are more likely to have distorted perceptions
By Chas Newkey-Burden, The Week UK
-
Full-body scans: more panic than panacea?
The Explainer Hailed as the 'future of medicine' by some, but not all experts are convinced
By The Week UK
-
The Last of Us, series two: 'post-apocalyptic television at its peak'
The Week Recommends Second instalment of hit show is just as 'gutsy' and 'thoughtful' as the first
By Irenie Forshaw, The Week UK
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
By Peter Weber, The Week US
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
By Justin Klawans, The Week US
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
By Peter Weber, The Week US
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
By Peter Weber, The Week US
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US